Login / Signup

Effects of low-dose methotrexate with MMI in patients with Graves' disease: results of a randomized clinical trial.

Pu XieLiyun ShenRongguang PengYanqiu WangQinglei YinXinxin ChenZhou JinYanqiu WangWeiqing WangShu WangYulin Zhou
Published in: The Journal of clinical endocrinology and metabolism (2024)
Supplemental MTX with MMI resulted in higher discontinuation rate and improvement in decreased TRAb levels to homeostatic levels faster than methimazole treatment alone at months 12-18.
Keyphrases
  • low dose
  • high dose
  • smoking cessation